Alembic to expand their U.S. commercial portfolio with FDA-approved PIVYA for the treatment of women with uncomplicated ...

The rising global incidence of Type 1 diabetes mellitus (T1DM) calls for innovative research to further explore its pathophysiological mechanisms, improve early detection, and refine treatment ...

Acute generalized exanthematous pustulosis is a rare drug-induced eruption that is characterized by acute, nonfollicular sterile pustules on an erythematous and edematous base.

Recent studies imply that acute generalized exanthematous pustulosis (AGEP) is a well orchestrated, cell-mediated, immunologic reaction with afferent and efferent pathways.

Medically reviewed by Alex Yampolsky, PharmD Hydroxyzine (whose brand names include Vistaril) and Benadryl (the brand name of diphenhydramine) are both first-generation antihistamines and share many ...

Ready-to-infuse sepsis therapy marks new advancement in time-critical treatment LONDON, July 2, 2025 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational ...

Severe Cutaneous Adverse Reactions: Including erythema multiforme, Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), drug reaction with eosinophilia and systemic symptoms (DRESS), and ...

Exanthematous Drug Eruption (EDE) Most drug eruptions manifest with erythematous macules and papules, giving them an appearance that may be referred to as exanthematous, mobilliform, or scarlatiniform ...

Acute generalized exanthematous pustulosis, an infrequent adverse drug reaction, mainly results from drugs. Clinically, acute generalized exanthematous pustulosis manifests as a high fever, with skin ...

Understand the different types of pustular psoriasis, their triggers, and how to treat them. Get insights into managing symptoms and preventing complications ...